Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Tieniu Mei"'
Autor:
Moyuan Deng, Tieniu Mei, Tianyong Hou, Keyu Luo, Fei Luo, Aijun Yang, Bo Yu, Hao Pang, Shiwu Dong, Jianzhong Xu
Publikováno v:
Stem Cell Research & Therapy, Vol 13, Iss 1, Pp 1-1 (2022)
Externí odkaz:
https://doaj.org/article/2ad5ddb643f94fa5b6e2b00485a79f31
Autor:
Moyuan Deng, Tieniu Mei, Tianyong Hou, Keyu Luo, Fei Luo, Aijun Yang, Bo Yu, Hao Pang, Shiwu Dong, Jianzhong Xu
Publikováno v:
Stem Cell Research & Therapy, Vol 8, Iss 1, Pp 1-12 (2017)
Abstract Background The recruitment of a sufficient number of endogenous mesenchymal stem cells (MSCs) is the first stage of in-situ tissue regeneration. Transforming growth factor beta-3 (TGFβ3) could recruit stem or progenitor cells and endothelia
Externí odkaz:
https://doaj.org/article/9b76474ad74a4109a1caa5dda6157b92
Autor:
Fei Luo, Zhilin Li, Shiwu Dong, Junchao Xing, Tieniu Mei, Zehua Zhang, Jianzhong Xu, Aijun Yang, Zhao Xie, Keyu Luo, Zhiqiang Li, Tianyong Hou
Publikováno v:
Acta Biomaterialia. 53:470-482
Easily accessible and effective bone grafts are in urgent need in clinic. The selective cell retention (SCR) strategy, by which osteogenesis-related cells and factors are enriched from bone marrow into bio-scaffolds, holds great promise. However, the
Autor:
Peng Cheng, Li Yao, Xiaoliang Gao, Qinyu Ma, Junchao Xing, Keyu Luo, Ning Ding, Zhilin Li, Jianhua Li, Tieniu Mei, Jianzhong Xu, Ce Dou, Yun Bai, Fei Luo, Chuan Liu
Publikováno v:
Journal of cellular physiology. 233(9)
Nitrogen-containing bisphosphonates including alendronate (ALN) are the current first line antiresorptive drug in treating osteoporosis. In our study, we found that ALN administration impaired the secretion of platelet derived growth factor-BB (PDGF-
Autor:
Keyu Luo, Jianzhong Xu, Bo Yu, Aijun Yang, Tieniu Mei, Shiwu Dong, Hao Pang, Moyuan Deng, Fei Luo, Tianyong Hou
Publikováno v:
Stem Cell Research & Therapy, Vol 8, Iss 1, Pp 1-12 (2017)
Stem Cell Research & Therapy
Stem Cell Research & Therapy
Background The recruitment of a sufficient number of endogenous mesenchymal stem cells (MSCs) is the first stage of in-situ tissue regeneration. Transforming growth factor beta-3 (TGFβ3) could recruit stem or progenitor cells and endothelial cells t
Autor:
Zehua Zhang, Tieniu Mei, Jianzhong Xu, Keyu Luo, Moyuan Deng, Shiwu Dong, Fei Luo, Zhiqiang Li, Zhao Xie, Tianyong Hou
Publikováno v:
Tissue engineering. Part C, Methods. 22(6)
Cell adhesion is an important property of biomaterials used in selective cell retention (SCR) technology, which fabricates bone grafts rapidly in clinical settings. This could be improved by physical and biologic manipulations. To facilitate retentio